Supermax Bhd (XKLS:7106) EBIT: RM-335.2 Mil (TTM As of Mar. 2026)


XKLS:7106 Supermax Corp Bhd XKLS:7106
51 GF Score
Price RM0.28
GF Value RM0.68
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Supermax Bhd EBIT?

Supermax Bhd XKLS:7106 51 EBIT is RM-335.2 Mil as of Mar. 2026. GuruFocus rates XKLS:7106 with a GF Score™ of 51/100 and a GF Value™ of RM0.68 (Possible Value Trap). The stock has 6 warning signs investors should review.

Supermax Bhd's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was RM-37.8 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was RM-335.2 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Supermax Bhd's annualized ROC % for the quarter that ended in Mar. 2026 was -4.95%. Supermax Bhd's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -5.03%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Supermax Bhd's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -89.51%.


Supermax Bhd  (XKLS:7106) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Supermax Bhd's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-163.396 * ( 1 - 0% )/( (3264.41 + 3343.012)/ 2 )
=-163.396/3303.711
=-4.95 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=4166.332 - 144.579 - ( 757.343 - max(0, 320.115 - 1084.918+757.343))
=3264.41

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=4128.455 - 147.853 - ( 637.59 - max(0, 335.767 - 991.24+637.59))
=3343.012

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Supermax Bhd's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-151.392/( ( (2854.53 + max(129.978, 0)) + (2911.517 + max(122.721, 0)) )/ 2 )
=-151.392/( ( 2984.508 + 3034.238 )/ 2 )
=-151.392/3009.373
=-5.03 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(72.349 + 149.143 + 84.307) - (144.579 + 0 + 31.242)
=129.978

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(69.656 + 188.973 + 53.363) - (147.853 + 0 + 41.418)
=122.721

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Supermax Bhd's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=-335.194/374.458
=-89.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Supermax Bhd EBIT Related Terms


Supermax Bhd EBIT Historical Data

* Premium members only.

The historical data trend for Supermax Bhd's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Supermax Bhd EBIT Chart

Supermax Bhd Annual Data
Trend Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,028.11 1,065.21 -182.27 -174.27 -190.29

Supermax Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.00 -99.38 -141.38 -56.59 -37.85

XKLS:7106 vs ISRG, BDX, MDLN: EBIT Comparison

For the Medical Instruments & Supplies subindustry, Supermax Bhd's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Supermax Bhd EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Supermax Bhd's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Supermax Bhd's EV-to-EBIT falls into.


XKLS:7106
51GF Score
Supermax Corp Bhd XKLS:7106
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Supermax Bhd EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-335.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of RM-335.2 Mil mean?
Supermax Bhd (XKLS:7106) has a EBIT of RM-335.2 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Supermax Bhd.
Is Supermax Bhd's EBIT too high?
Supermax Bhd's current EBIT is RM-335.2 Mil. Overall, Supermax Bhd has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Supermax Bhd's EBIT compare to ISRG and BDX?
Supermax Bhd's EBIT of RM-335.2 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Supermax Bhd. Supermax Bhd's current EBIT is RM-335.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Supermax Bhd stock overvalued right now?
Based on GuruFocus' analysis, Supermax Bhd (XKLS:7106) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.68, compared to a current price of RM0.28 — trading 59.6% below its estimated fair value. The current EBIT is RM-335.2 Mil. Supermax Bhd's overall GF Score™ is 51/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Supermax Bhd (XKLS:7106), the current EBIT is RM-335.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Supermax Bhd (XKLS:7106) Overvalued in 2026?

Based on GuruFocus' analysis, Supermax Bhd stock appears to be undervalued. The current stock price of RM0.28 is trading 59.6% below its estimated GF Value™ of RM0.68. GuruFocus considers Supermax Bhd to be Possible Value Trap.

Key valuation signals for XKLS:7106:

  • EBIT: RM-335.2 Mil
  • GF Value™: RM0.68 vs. price of RM0.28 (59.6% below fair value)
  • GF Score™: 51/100 with 6 warning signs

No single metric tells the full story. See the XKLS:7106 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Supermax Bhd Business Description

Address Lot 38, Putra Industrial Park, Bukit Rahman Putra, Sungai Buloh, SGR, MYS, 40160
Supermax Corp Bhd is an investment holding company. Along with its subsidiaries, the company operates as an international manufacturer, distributor, and marketer of high-quality medical gloves and contact lenses. It offers various types of latex gloves, which are exported to numerous countries. The company is organized into the following reportable operating segments: manufacturing of gloves, which generates the majority of revenue; investment holding; trading of gloves; and others. Geographically, it derives the majority of its revenue from Europe, with the remainder coming from Africa, Asia and Oceania, and North, Central, and South America.
51GF Score

Get the complete analysis for XKLS:7106

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.28
Price
RM0.68
GF Value